Advertisement
Clinical study| Volume 109, ISSUE 4, P282-287, September 2000

Download started.

Ok

Self-help weight loss versus a structured commercial program after 26 weeks: a randomized controlled study

Published:August 16, 2004DOI:https://doi.org/10.1016/S0002-9343(00)00494-0
Self-help weight loss versus a structured commercial program after 26 weeks: a randomized controlled study
Previous ArticleIncidence trends for colorectal cancer in California: implications for current screening practices
Next ArticleAssociation between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis

      Abstract

      PURPOSE: There have been few randomized controlled trials of commercial weight-loss programs. This ongoing study compares the effects of a self-help program and a commercial program on weight loss and other measures of obesity in overweight and obese men and women.
      SUBJECTS AND METHODS: We report the results of the first 26 weeks of a multicenter, randomized, 2-year study of 423 subjects who had a body mass index of 27 to 40 kg/m2. Subjects were randomly assigned to either a self-help program, consisting of two 20-minute sessions with a nutritionist and provision of printed materials and other self-help resources, or to attendance at meetings of a commercial program (Weight Watchers). Outcome measures were changes in body weight, body mass index, waist circumference, and body fat. Changes in serum homocysteine levels were measured in a subsample of participants during the first 12 weeks.
      RESULTS: After 26 weeks, subjects in the commercial program, as compared with those in the self-help program, had greater decreases in body weight [mean (± SD) −4.8 ± 5.6 vs −1.4 ± 4.7 kg] and body mass index (−1.7 ± 1.9 vs −0.5 ± 1.6 kg/m2, both P <0.001) in intention-to-treat analyses. Among subjects measured at week 26, mean waist circumference (−4.3 ± 10.5 vs −0.7 ± 12.7 cm) and fat mass (−3.8 ± 7.0 vs −1.5 ± 7.6 kg, both P <0.05) also decreased more among subjects in the commercial program. Mean serum homocysteine levels improved in the commercial program compared with self-help (−0.5 ± 1.3 vs 0.9 ± 1.8 μM, P <0.05).
      CONCLUSIONS: A structured commercial weight-loss program is more likely to be effective for managing moderately overweight patients than brief counseling and self-help.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Connolly H.M.
        • Crary J.L.
        • McGoon M.D.
        • et al.
        Valvular heart disease associated with fenfluramine-phentermine.
        N Engl J Med. 1997; 337: 581-588
        View in Article

      2. Paul R. Thomas, ed., and the Food and Nutrition Board, Institute of Medicine, Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity. Weighing the Options: Criteria for Evaluating Weight Management Programs. Washington, DC: National Academy Press, 1995.

        View in Article
        • Levy A.S.
        • Heaton A.W.
        Weight control practices of U.S. adults trying to lose weight.
        Ann Int Med. 1993; 119: 661-666
        View in Article
        • Rippe J.M.
        • Price J.M.
        • Hess S.A.
        • et al.
        Improved psychological well-being, quality of life and health practices in moderately overweight women participating in a 12-week structured weight loss program.
        Obes Res. 1998; 6: 208-218
        View in Article
        • Lowe M.R.
        • Miller-Kovach K.
        • Frye N.
        • Phelan S.
        An initial evaluation of a commercial weight loss program.
        Obes Res. 1999; 7: 51-59
        View in Article

      6. Taylor CB, Stunkard AJ. Public health approaches to weight control. In: Stunkard AJ, Wadden TA, eds. Obesity: Theory and Therapy, 2nd ed. New York: Raven Press, 1993:335–353.

        View in Article
        • Wadden T.A.
        • Foster G.D.
        • Letizia K.A.
        • Stunkard A.J.
        A multicenter evaluation of a proprietary weight reduction program for the treatment of marked obesity.
        Arch Intern Med. 1992; 152: 961-966
        View in Article

      8. The U.S. Weight Loss and Diet Control Market, 5th ed. Tampa, FL: Marketdata Enterprises, 1998.

        View in Article
        • Nygard O.
        • Refsum H.
        • Ueland P.M.
        • Vollset S.E.
        Major lifestyle determinants of plasma total homocysteine distribution.
        Am J Clin Nutr. 1998; 67: 263-270
        View in Article

      10. Eating Smart, National Cattlemen’s Beef Association, Chicago, IL 1996.

        View in Article

      11. Fitting Fitness In, National Cattlemen’s Beef Association, Chicago, IL 1996.

        View in Article

      12. Physical Activity, and Cardiovascular Health. NIH Consensus Statement. December 18–20, 1995;13(3):1–33.

        View in Article

      13. U.S. Department of Health and Human Services, PHS. NHANES III Anthropometric Procedures Video. Washington, DC: US Government Printing Office, Public Health Service, 1996.

        View in Article
        • Sheiner L.B.
        • Rubin D.B.
        Intention-to-treat analysis and the goals of clinical trials.
        Clin Pharmacol Ther. 1995; 57: 6-15
        View in Article
        • Kannel W.B.
        • Cupples L.A.
        • Ramaswami R.
        • et al.
        Regional obesity and risk of cardiovascular disease.
        J Clin Epidemiol. 1991; 44: 183-190
        View in Article
        • National Institutes of Health
        Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the Evidence Report.
        Obes Res. 1998; 6: 51S-210S
        View in Article
        • Bray G.A.
        • Blackburn G.L.
        • Ferguson J.M.
        • et al.
        Sibutramine produces dose-related weight loss.
        Obes Res. 1999; 7: 189-198
        View in Article
        • Davidson M.H.
        • Hauptman J.
        • DiGirolamo M.
        • et al.
        Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat.
        JAMA. 1999; 281: 235-242
        View in Article
        • Jeffery R.W.
        • Drenowski A.
        • Epstein L.H.
        • et al.
        Long-term maintenance of weight loss.
        Health Psych. 2000; 19: 5-16
        View in Article
        • Volkmar F.R.
        • Stunkard A.J.
        • Woolston J.
        • Bailey R.A.
        High attrition rates in commercial weight reduction programs.
        Arch Intern Med. 1981; 141: 426-428
        View in Article
        • Jeffery R.W.
        • Bjornson-Benson W.M.
        • Rosenthal B.S.
        • et al.
        Correlates of weight loss and its maintenance over two years of follow-up among middle-aged men.
        Prev Med. 1984; 13: 155-168
        View in Article
        • Wadden T.A.
        • Foster G.D.
        • Wand J.
        • et al.
        Clinical correlates of short- and long-term weight loss.
        Am J Clin Nutr. 1992; 56: 271s-274s
        View in Article
        • Rössner S.
        Long-term intervention strategies in obesity treatment.
        Int J Obes. 1995; 19: S29-S33
        View in Article
        • Boushey C.J.
        • Beresford S.A.A.
        • Omenn G.S.
        • Motulsky A.G.
        Quantitative assessment of plasma homocysteine as a risk factor for vascular disease.
        JAMA. 1995; 274: 1049-1057
        View in Article

      25. Position of the American Dietetic Association. Vitamin and mineral supplementation. J Am Diet Assoc. 1996;96:73–77.

        View in Article

      Article info

      Publication history

      Published online: August 16, 2004
      Accepted: May 19, 2000
      Received in revised form: May 19, 2000
      Received: July 7, 1999

      Footnotes

      ☆Supported by a grant from the Weight Watchers Foundation.

      Identification

      DOI: https://doi.org/10.1016/S0002-9343(00)00494-0

      Copyright

      © 2000 Excerpta Medica Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX